11-64950424-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001037225.3(MAJIN):c.154G>A(p.Val52Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,612,598 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001037225.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAJIN | NM_001037225.3 | c.154G>A | p.Val52Ile | missense_variant | 5/11 | ENST00000301896.6 | NP_001032302.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAJIN | ENST00000301896.6 | c.154G>A | p.Val52Ile | missense_variant | 5/11 | 5 | NM_001037225.3 | ENSP00000301896 | P1 | |
MAJIN | ENST00000432175.5 | c.154G>A | p.Val52Ile | missense_variant | 4/10 | 1 | ENSP00000395273 | P1 | ||
MAJIN | ENST00000530444.5 | c.148-2959G>A | intron_variant | 1 | ENSP00000434568 | |||||
MAJIN | ENST00000530735.5 | c.*523G>A | 3_prime_UTR_variant, NMD_transcript_variant | 5/12 | 2 | ENSP00000432213 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151534Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251282Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135816
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1460974Hom.: 0 Cov.: 35 AF XY: 0.00000963 AC XY: 7AN XY: 726832
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151624Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74020
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at